Home Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis
Article
Licensed
Unlicensed Requires Authentication

Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis

  • Pauline M. Camacho and Norma A. Lopez
Published/Copyright: October 1, 2008

Abstract

Background: We currently have guidelines that allow us to use bone densitometry in the diagnosis and management of osteoporosis. The role of biochemical markers of bone turnover (BTMs) is less well defined. Serum and urine BTM patterns in treated and untreated osteoporotic patients have been studied to help us define their role. The aim of this review is to present data which helps elucidate the current role and limitation of BTMs in the management of osteoporosis.

Method: A search of the literature on BTMs was performed. References with keywords, such as bone turnover markers, biochemical markers, monitoring therapy and monitoring osteoporosis, were used.

Results: Literature describing the nature and limitation of currently available BTMs was reviewed. The clinical use and limitation of BTMs in assessing fracture risk reduction, bone mineral density (BMD) and response to therapy is available, whereas definitive guidelines have not yet been created.

Conclusions: BTMs offer a potential non-invasive and reliable way of assessing skeletal activity, studying drug effects and response to therapies, assessing fracture risk and predicting other skeletal parameters, such as bone loss, BMD and bone mass. A 30%–70% reduction in bone resorption markers can be achieved with antiresorptive therapy, and 30%–50% increase in bone formation markers with anabolic therapy. We recommend that clinicians understand and incorporate the measurement of BTMs in the management of osteoporosis.

Clin Chem Lab Med 2008;46:1345–57.


Corresponding author: Pauline Camacho, Loyola University Osteoporosis and Metabolic Bone Disease Center, Maywood, IL 60153, USA

Received: 2008-2-15
Accepted: 2008-7-15
Published Online: 2008-10-01
Published in Print: 2008-10-01

©2008 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Review
  2. Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis
  3. Minireview
  4. Is serum procalcitonin able to predict long-term kidney morbidity from urinary tract infections in children?
  5. Genetics and Molecular Diagnostics
  6. Association between the 2756A> G variant in the gene encoding methionine synthase and myocardial infarction in Tunisian patients
  7. Common 894G>T single nucleotide polymorphism in the gene coding for endothelial nitric oxide synthase (eNOS) and risk of congenital heart defects
  8. New sequence variants in BRCA1 and BRCA2 genes detected by high-resolution melting analysis in an elderly healthy female population in Croatia
  9. Enzyme-free signal amplification of analyte in a single closed tube by fluorescent hybridization chain reaction
  10. Five X-chromosome short tandem repeats in a Western Mexican population
  11. General Clinical Chemistry and Laboratory Medicine
  12. Prolyl-hydroxyproline dipeptide in non-hydrolyzed morning urine and its value in postmenopausal osteoporosis
  13. Methionine metabolism in an animal model of sepsis
  14. Hypochlorous acid is a potent inactivator of human plasminogen at concentrations secreted by activated granulocytes
  15. Association of serum γ-glutamyltransferase with C-reactive protein levels and white blood cell count in Korean adults
  16. Immunoradiometric determination of thyroglobulin in serum samples by time calibration transfer
  17. Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients
  18. Measurement of 10,11-dihydro-10-hydroxy-carbamazepine in serum and plasma by high-performance liquid chromatography
  19. The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population
  20. Reference Values and Biological Variations
  21. Analytical quality goals for parathyroid hormone based on biological variation
  22. Preanalytical effects of pneumatic tube transport on routine haematology, coagulation parameters, platelet function and global coagulation
  23. Validation and Outcome Studies
  24. Automated immunoassay methods for ferritin: recovery studies to assess traceability to an international standard
  25. An expert system for the classification of serum protein electrophoresis patterns
  26. Impact of a satellite laboratory on turnaround times for the emergency department
  27. Effect of ampicillin-sulbactam on clinical capillary zone electrophoresis of serum proteins
  28. Guidelines and Recommendations
  29. Protein standardization V: value transfer. A practical protocol for the assignment of serum protein values from a Reference Material to a Target Material
  30. Letter to the Editor
  31. Biological variability evaluation and comparison of three different methods for C-peptide measurement
  32. Abstracts
  33. 10.1515/CCLM.2008.361
Downloaded on 16.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.310/html
Scroll to top button